Blanket Purchase Agreement V797D70105-36C24122A0013

Award Date 11/8/21
Last Date to Order 11/7/23
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Blanket Purchase Agreement was awarded as a single award by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 to Roche Diagnostics Corporation. The agreement is for the delivery of CPT VIROLOGY AND SARS COV-2 TEST KITS, with a potential value of $1,712,900. The period of performance under the BPA is from date of award on October 21, 2020 through the last date orders may be placed on October 20, 2021. As a single award BPA issued by the VA...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded Roche Diagnostics Corporation an indefinite delivery contract with a potential value of $773,160 to provide COVID-19 reagents. Under this contract, Roche was issued a firm fixed price delivery order worth $345,452.54 to supply COVID-19 test kits and materials for use in Castleton, Indiana, with delivery required by November 30, 2020. The original solicitation sought diagnostic test...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single award Indefinite Delivery Contract to Roche Diagnostics Corporation for COVID-19 diagnostic testing supplies. The contract established a potential value of $4.8 million for Roche Cobas 6800 SARS-CoV-2 testing kits to be delivered from May 2022 through April 2024. Two firm fixed price delivery orders were subsequently issued against the contract. The first, valued at $442,784,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VA-VHA) awarded three Blanket Purchase Agreement (BPA) call contracts to Roche Diagnostics Corporation under the Multiple Award Schedule (MAS) contract vehicle. The BPAs have potential values ranging from approximately $400,000 to $520,000 and completion dates from April 2022 through April 2026. Roche Diagnostics Corporation will provide diagnostic testing services and related supplies and...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 10, has awarded an Indefinite Delivery Contract (IDC) worth a ceiling value of $488,315.80 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, which does not utilize a small business set-aside, is for the provision of SARS-CoV-2 and Cytomegalovirus (CMV) test and control kits to support VA hospitals and medical facilities. Under a...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide COVID-19 and influenza diagnostic testing materials. The single award IDV has a potential value of $6.2 million and a period of performance through September 2024. Three firm fixed price delivery orders have been issued against the IDV to date. The orders procure COVID-19 and influenza reagents and supplies...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Roche Diagnostics Corporation three blanket purchase agreement calls to provide integrated chemistry services in support of VHA programs. The BPAs were awarded against Roche's Critical Analyzers, Laboratory schedule at the General Services Administration with a combined value of $8.2M. Performance will take place at Roche's Castleton, Indiana facility through January 2026. The...
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $1,041,901.25, allows the VA network to acquire CPRR microbiology reagents from Roche on an as-needed basis over the contract's term through September...
This is a 5-year Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The BPA, with a total ceiling value of $80,000, provides the VA with Influenza A/B and Strep A test kits and quality control reagents for Roche's Cobas Liat equipment. Roche Diagnostics will...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Roche Diagnostics Corporation two Blanket Purchase Agreement Call contracts under the Critical Analyzers, Laboratory Government-Wide Acquisition Contract master schedule to provide COVID-19 and SARS testing services. The first BPA Call, valued at $557,921.64, was awarded on November 17, 2021 for CPT virology and SARS CoV-2 testing services in Castleton, Indiana between November 17, 2021 and November 16, 2022. The second BPA Call, valued at $750,000, was awarded on November 8, 2022 for similar testing services in Castleton, Indiana between November 8, 2022 and November 7, 2023.

Both firm fixed price contracts support Roche Diagnostics Corporation in offering coronavirus polymerase chain reaction testing kits, reagents and related supplies to assist the VA in detecting COVID-19 and severe acute respiratory syndrome coronavirus 2. The BPAs aim to procure these diagnostic testing services and products for Veterans Health Administration facilities in the specified region. As the leading global manufacturer of in vitro diagnostics and life science products, Roche Diagnostics Corporation is well positioned to provide these essential COVID-19 and respiratory pathogen detection capabilities to the VA network.

Generated 1/4/24, 5:25 PM